Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026)
Johnson & Johnson recorded quarterly Long-Term Deferred Tax of $6.7 billion in Q1 2026, down 2.14% quarter-over-quarter from $6.9 billion in Q4 2025, and down 20.78% year-over-year from $8.5 billion in Q1 2025.
Johnson & Johnson's Long-Term Deferred Tax history runs 18 years deep, the most recent figure standing at $6.7 billion for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 20.78% year-over-year to $6.7 billion; the TTM figure through Mar 2026 stood at $6.7 billion (down 20.78% YoY), while the FY2025 annual figure was $6.9 billion, down 34.29% from the prior year.
- Long-Term Deferred Tax came in at $6.7 billion for Q1 2026 at Johnson & Johnson, down from $6.9 billion in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 billion in Q4 2024 to a low of $6.7 billion in Q3 2025.
- A 5-year average of $8.8 billion and a median of $9.1 billion in 2023 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax increased 19.79% in 2022 and slumped 34.29% in 2025, its largest moves.
- Johnson & Johnson's Long-Term Deferred Tax stood at $9.4 billion in 2022, then slipped by 1.2% to $9.3 billion in 2023, then rose by 12.74% to $10.5 billion in 2024, then plunged by 34.29% to $6.9 billion in 2025, then retreated by 2.14% to $6.7 billion in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $6.7 billion, $6.9 billion, and $6.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 6.73 Bn |
| Dec 28, 2025 | 6.87 Bn |
| Sep 28, 2025 | 6.67 Bn |
| Jun 29, 2025 | 6.80 Bn |
| Mar 30, 2025 | 8.49 Bn |
| Dec 29, 2024 | 10.46 Bn |
| Sep 29, 2024 | 9.35 Bn |
| Jun 30, 2024 | 9.00 Bn |
| Mar 31, 2024 | 10.31 Bn |
| Dec 31, 2023 | 9.28 Bn |
| Oct 1, 2023 | 9.26 Bn |
| Jul 2, 2023 | 8.78 Bn |
| Apr 2, 2023 | 8.82 Bn |
| Jan 1, 2023 | 8.95 Bn |
| Oct 2, 2022 | 9.39 Bn |
| Jul 3, 2022 | 9.51 Bn |
| Apr 3, 2022 | 9.94 Bn |
| Jan 2, 2022 | 10.22 Bn |
| Oct 3, 2021 | 10.65 Bn |
| Jul 4, 2021 | 10.80 Bn |
| Apr 4, 2021 | 8.32 Bn |
| Jan 3, 2021 | 8.53 Bn |
| Sep 27, 2020 | 7.82 Bn |
| Jun 28, 2020 | 7.81 Bn |
| Mar 29, 2020 | 7.54 Bn |
| Dec 29, 2019 | 7.82 Bn |
| Sep 29, 2019 | 7.70 Bn |
| Jun 30, 2019 | 7.65 Bn |
| Mar 31, 2019 | 7.53 Bn |
| Dec 30, 2018 | 11.41 Bn |
| Sep 30, 2018 | 8.08 Bn |
| Jul 1, 2018 | 8.47 Bn |
| Apr 1, 2018 | 8.79 Bn |
| Dec 31, 2017 | 9.90 Bn |
| Oct 1, 2017 | 6.30 Bn |
| Jul 2, 2017 | 6.11 Bn |
| Apr 2, 2017 | 6.38 Bn |
| Jan 1, 2017 | 10.14 Bn |
| Oct 2, 2016 | 5.90 Bn |
| Jul 3, 2016 | 5.78 Bn |
| Apr 3, 2016 | 5.68 Bn |
| Jan 3, 2016 | 5.49 Bn |
| Sep 27, 2015 | 3.15 Bn |
| Jun 28, 2015 | 3.09 Bn |
| Mar 29, 2015 | 3.06 Bn |
| Dec 28, 2014 | 6.20 Bn |
| Sep 28, 2014 | 3.35 Bn |
| Jun 29, 2014 | 3.38 Bn |
| Mar 30, 2014 | 3.69 Bn |
| Dec 29, 2013 | 10.84 Bn |
| Sep 29, 2013 | 4.60 Bn |
| Jun 30, 2013 | 4.74 Bn |
| Mar 31, 2013 | 4.51 Bn |
| Dec 30, 2012 | 12.10 Bn |
| Sep 30, 2012 | 4.23 Bn |
| Jul 1, 2012 | 4.01 Bn |
| Apr 1, 2012 | 5.91 Bn |
| Jan 1, 2012 | 6.54 Bn |
| Oct 2, 2011 | 5.56 Bn |
| Jul 3, 2011 | 5.65 Bn |
| Apr 3, 2011 | 5.33 Bn |
| Jan 2, 2011 | 5.10 Bn |
| Oct 3, 2010 | 5.18 Bn |
| Jul 4, 2010 | 5.11 Bn |
| Apr 4, 2010 | 4.91 Bn |
| Jan 3, 2010 | 5.51 Bn |
| Sep 27, 2009 | 5.89 Bn |
| Jun 28, 2009 | 5.87 Bn |